460 related articles for article (PubMed ID: 21918741)
21. Update on in hospital venous thromboembolism prophylaxis.
Bergqvist D
Eur J Vasc Endovasc Surg; 2007 Mar; 33(3):343-50. PubMed ID: 17236793
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
23. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
24. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
25. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
26. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
ten Cate-Hoek AJ; Prins MH
Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
[TBL] [Abstract][Full Text] [Related]
27. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
28. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Cohen AT; Nandini B; Wills JO; Ota S
Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
[TBL] [Abstract][Full Text] [Related]
29. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
30. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
31. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials.
Brown GA
J Arthroplasty; 2009 Sep; 24(6 Suppl):77-83. PubMed ID: 19628366
[TBL] [Abstract][Full Text] [Related]
33. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
Parpia S; Julian JA; Thabane L; Lee AY; Rickles FR; Levine MN
Contemp Clin Trials; 2011 Nov; 32(6):829-33. PubMed ID: 21777700
[TBL] [Abstract][Full Text] [Related]
34. Current concepts for the prevention of venous thromboembolism.
Bramlage P; Pittrow D; Kirch W
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():4-11. PubMed ID: 15701142
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
36. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
37. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
[TBL] [Abstract][Full Text] [Related]
39. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
[TBL] [Abstract][Full Text] [Related]
40. Safety of anticoagulant treatment in cancer patients.
Wilts IT; Bleker SM; Van Es N; Büller HR; Di Nisio M; Kamphuisen PW
Expert Opin Drug Saf; 2015 Aug; 14(8):1227-36. PubMed ID: 26059964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
